rs786205771
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_000719.7(CACNA1C):c.2317_2319delAAG(p.Lys773del) variant causes a conservative inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,892 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
CACNA1C
NM_000719.7 conservative_inframe_deletion
NM_000719.7 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.49
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-2584592-GAGA-G is Pathogenic according to our data. Variant chr12-2584592-GAGA-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 411734.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.2407_2409delAAG | p.Lys803del | conservative_inframe_deletion | 16/50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.2482_2484delAAG | p.Lys828del | conservative_inframe_deletion | 17/48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.2407_2409delAAG | p.Lys803del | conservative_inframe_deletion | 16/47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.2407_2409delAAG | p.Lys803del | conservative_inframe_deletion | 16/47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.2407_2409delAAG | p.Lys803del | conservative_inframe_deletion | 16/47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.2407_2409delAAG | p.Lys803del | conservative_inframe_deletion | 16/47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.2392_2394delAAG | p.Lys798del | conservative_inframe_deletion | 17/48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.2392_2394delAAG | p.Lys798del | conservative_inframe_deletion | 17/47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.2308_2310delAAG | p.Lys770del | conservative_inframe_deletion | 16/47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.2317_2319delAAG | p.Lys773del | conservative_inframe_deletion | 16/46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000480911.6 | n.*924_*926delAAG | non_coding_transcript_exon_variant | 14/27 | 5 | ENSP00000437936.2 | ||||
CACNA1C | ENST00000480911.6 | n.*924_*926delAAG | 3_prime_UTR_variant | 14/27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460892Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 726730
GnomAD4 exome
AF:
AC:
1
AN:
1460892
Hom.:
AF XY:
AC XY:
0
AN XY:
726730
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Long QT syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | This variant, c.2317_2319del, results in the deletion of 1 amino acid(s) of the CACNA1C protein (p.Lys773del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with clinical features of CACNA1C-related conditions (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 411734). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2024 | The c.2317_2319delAAG variant (also known as p.K773del) is located in coding exon 16 of the CACNA1C gene. This variant results from an in-frame AAG deletion at nucleotide positions 2317 to 2319. This results in the in-frame deletion of a lysine at codon 773. This alteration has been reported in individuals with long QT syndrome and was found to be de novo in one individual (Ambry internal data; external communication). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the majority of available evidence to date, this variant is likely to be pathogenic for CACNA1C-related long QT syndrome/Timothy syndrome; however, its clinical significance for CACNA1C-related neurodevelopmental disorder is uncertain. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at